Stocks and Investing Stocks and Investing
Fri, March 10, 2023
Thu, March 9, 2023

Andreas Argyrides Upgraded (AQST) to Buy and Increased Target to $4 on, Mar 9th, 2023


Published on 2024-10-28 02:12:23 - WOPRAI, Andreas Argyrides
  Print publication without navigation


Andreas Argyrides of Wedbush, Upgraded "Aquestive Therapeutics, Inc." (AQST) to Buy and Increased Target from $3 to $4 on, Mar 9th, 2023.

Andreas, nor any peers, have made any analyst calls on AQST in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Contributing Sources